美国遗传性胰腺炎:生存率与胰腺癌发生率
该研究前瞻性纳入1995至2013年美国217名PRSS1突变携带者(181名有症状),随访至2015年12月31日,发现中位总生存期为79.3年,胰腺癌标准化发病比为59(95%CI 19-138),70岁时累积风险为7.2%(95%CI 0-15.4)。
要点
- PRSS1携带者胰腺癌风险显著高于年龄和性别匹配的SEER数据(SIR 59,95%CI 19-138)。
- 70岁时胰腺癌累积风险为7.2%(95%CI 0-15.4)。
- 中位总生存期为79.3年(IQR 72.2-85.2)。
核心结论
- 研究证实了先前关于PRSS1受试者生存率和胰腺癌SIR的观察结果,尽管胰腺癌风险显著升高,但其累积风险远低于既往报告。
研究设计与样本
- 前瞻性招募1995年至2013年的遗传性胰腺炎先证者及家庭成员,完成医学和家族史问卷并提供血液进行DNA检测,共217名PRSS1携带者(181名有症状)组成研究队列,随访至2015年12月31日。
主要发现
- 最常见的突变为p.R122H(83.9%)和p.N29I(11.5%)。
- 37名PRSS1携带者(30名有症状,7名无症状)在研究结束时死亡,其中5人死于胰腺癌。
- 中位总生存期为79.3年(IQR 72.2-85.2)。
- 胰腺癌风险显著高于年龄和性别匹配的SEER数据(SIR 59,95%CI 19-138)。
- 70岁时胰腺癌累积风险为7.2%(95%CI 0-15.4)。
关键数值与推荐
- 胰腺癌风险显著高于年龄和性别匹配的SEER数据(SIR 59,95%CI 19-138)。
- 70岁时胰腺癌累积风险为7.2%(95%CI 0-15.4)。
- 中位总生存期为79.3年(IQR 72.2-85.2)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Hereditary pancreatitis (HP), an autosomal dominant disease typically caused by mutations in PRSS1, has a broad range of clinical characteristics and high cumulative risk of pancreatic cancer. We describe survival and pancreatic cancer risk in the largest HP cohort in the US. METHODS: HP probands and family members prospectively recruited from 1995 to 2013 completed medical and family history questionnaires, and provided blood for DNA testing. Overall survival (until 12/31/2015) was determined from the Social Security Death Index (SSDI), National Death Index (NDI), and family members. Cause of death was obtained from the NDI. RESULTS: 217 PRSS1 carriers (181 symptomatic) formed the study cohort. The most frequently detected mutations were p.R122H (83.9%) and p.N29I (11.5%). Thirty-seven PRSS1 carriers (30 symptomatic, 7 asymptomatic) were deceased at conclusion of the study (5 from pancreatic cancer). Median overall survival was 79.3 years (IQR 72.2-85.2). Risk of pancreatic cancer was significantly greater than age- and sex- matched SEER data (SIR 59, 95% CI 19-138), and cumulative risk was 7.2% (95% CI 0-15.4) at 70 years. DISCUSSION: We confirm prior observations on survival and pancreatic cancer SIR in PRSS1 subjects. Although risk of pancreatic cancer was significantly high in these patients, its cumulative risk was much lower than previous reports.
引用
- Shelton CA, Umapathy C, Stello K, et al. Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer. Am J Gastroenterol. 2018. PMID: 30018304. doi:10.1038/s41395-018-0194-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。